Ngā hua rapu - Shuyu Dan Li
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications mā Shuyu Dan Li, Meng Ma, Hui Li, Aneta Waluszko, Tatyana Sidorenko, Eric E. Schadt, David Y. Zhang, Rong Chen, Fei Ye
I whakaputaina 2017Artigo -
2
A composite biomarker of neutrophil-lymphocyte ratio and hemoglobin level correlates with clinical response to PD-1 and PD-L1 inhibitors in advanced non-small cell lung cancers mā Kristin L. Ayers, Meng Ma, Gaspard Debussche, David Corrigan, Jonathan McCafferty, Kyeryoung Lee, Scott Newman, Xiang Zhou, Fred R. Hirsch, Philip C. Mack, Jane J. Liu, Eric E. Schadt, Rong Chen, Shuyu Dan Li
I whakaputaina 2021Artigo -
3
Comparative analyses of population-scale phenomic data in electronic medical records reveal race-specific disease networks mā Benjamin S. Glicksberg, Li Li, Marcus A. Badgeley, Khader Shameer, Roman Kosoy, Noam D. Beckmann, Nam Pho, Jörg Hakenberg, Meng Ma, Kristin L. Ayers, Gabriel E. Hoffman, Shuyu Dan Li, Eric E. Schadt, Chirag J. Patel, Rong Chen, Joel T. Dudley
I whakaputaina 2016Artigo -
4
Melanocortin 4 Receptor Pathway Dysfunction in Obesity: Patient Stratification Aimed at MC4R Agonist Treatment mā Kristin L. Ayers, Benjamin S. Glicksberg, Alastair S. Garfield, Simonne Longerich, Joseph White, Yang Pengwei, Lei Du, Thomas W. Chittenden, Jeffery R. Gulcher, Sophie Roy, Fred T. Fiedorek, Keith Gottesdiener, Sarah S. Cohen, Kari E. North, Eric E. Schadt, Shuyu Dan Li, Rong Chen, Lex H.T. Van der Ploeg
I whakaputaina 2018Artigo -
5
Genomic profiling reveals mutational landscape in parathyroid carcinomas mā Chetanya Pandya, Andrew Uzilov, Justin Bellizzi, Chun Yee Lau, Aye S. Moe, Maya Strahl, Wissam Hamou, Leah Newman, Marc Y. Fink, Yevgeniy Antipin, Willie Yu, Mark Stevenson, Branca Cavaco, Bin Tean Teh, Rajesh V. Thakker, Hans Morreau, Eric E. Schadt, Robert Sebra, Shuyu Dan Li, Andrew Arnold, Rong Chen
I whakaputaina 2017Artigo -
6
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling mā Alexa B. Schrock, Shuyu Dan Li, Garrett M. Frampton, James Suh, Eduardo Braun, Ranee Mehra, Steven C. Buck, José A. Bufill, Nir Peled, Nagla Abdel Karim, Kuang-Yang Hsieh, Manuel I. Doria, James A. Knost, Rong Chen, Sai‐Hong Ignatius Ou, Jeffrey S. Ross, Philip J. Stephens, Paul A. S. Fishkin, Vincent A. Miller, Siraj M. Ali, Balázs Halmos, Jane J. Liu
I whakaputaina 2017Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Biology
Internal medicine
Medicine
Gene
Genetics
Cancer research
Lung cancer
Oncology
Adenocarcinoma
Cancer
Germline mutation
Mutation
ROS1
Targeted therapy
Allele
Biochemistry
Bioinformatics
Biomarker
Botany
Cartography
Chemistry
Colorectal cancer
Computer science
Confidence interval
DNA mismatch repair
DNA repair
Data mining
Data science
Disease
Endocrinology